63-year old patient living with ascites talks about the alfapump® "improved quality of life"

Sequana Medical’s alfapump provides an innovative treatment solution for the management of refractory ascites due to liver cirrhosis and malignant ascites. The alfapump is a fully implantable battery-operated pump system that collects ascites as it forms and pumps it into the bladder, where it is excreted naturally through urination. By automatically and continuously moving ascites from the abdomen to the bladder, the alfapump is preventing fluid build-up and possible complications, improving patients’ quality of life and nutrition, and potentially reducing hospital visits and healthcare costs. The alfapump is approved in Europe and has received breakthrough device designation from the US FDA.
Ascites has a dramatic impact on the quality of life of patients. Patients suffering from ascites are immobile and very restricted in their daily activity, and often report feelings of isolation and depression. Family members are also affected because of the need for extensive care and frequent hospital visits for paracentesis, and they constant worry about their relatives’ condition.
Patients with refractory liver ascites who were implanted with the alfapump experienced a substantial improvement in quality of life. Patients testified about their improved activity and mobility, and generally felt much better than before their implantation with the alfapump. These patients also experienced improvements in their eating, breathing and sleeping and were able to perform everyday tasks like cooking for their family and going on vacation without worrying about getting back in time for paracentesis. Family members also experienced a positive change and were able to enjoy life together with their relatives again. In short, the alfapump makes patients strong and independent enough to do anything they want, and lead regular lives